Skin Laxity After Ozempic and Mounjaro: Which Treatments Can Help?
GLP-1 receptor agonists such as semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro) have transformed the landscape of medical weight loss. For many patients, the results are significant, substantial reductions in body weight over a relatively short period. But rapid fat loss, particularly from the face, abdomen, and arms, frequently leaves behind a problem that medication alone cannot address: loose, excess skin.
This blog examines why post-weight-loss skin laxity occurs, which areas are most commonly affected, and what treatment options are available for patients in London looking to address the aesthetic consequences of GLP-1-assisted weight loss.
As a leading aesthetic clinic in Chelsea, Dr Sultan's practice has seen a marked increase in consultations from patients navigating exactly this concern.
Why Does Skin Laxity Occur After Rapid Weight Loss?
Skin has a degree of elasticity, but that elasticity has limits. When fat accumulates over time, the skin stretches to accommodate it. When fat is lost particularly rapidly, as is often the case with GLP-1 medications, the skin does not always contract at the same pace.
Several factors influence how well skin responds to weight loss:
• Age — skin elasticity naturally diminishes over time, reducing the skin's ability to retract
• Speed of weight loss — faster loss gives the skin less time to adapt
• Volume of weight lost — larger reductions in body weight typically produce more significant laxity
• Genetics — some individuals have inherently more elastic skin than others
• Sun exposure history and smoking — both accelerate collagen degradation
Patients using Ozempic or Mounjaro often lose weight more rapidly than through lifestyle modification alone. According to NICE guidance on semaglutide, average weight reductions of 10–15% of body weight are achievable, with some patients losing considerably more.
Which Areas Are Most Commonly Affected?
The areas most likely to show significant skin laxity following GLP-1-related weight loss are:
• Abdomen and belly — often the most pronounced area, particularly in patients who carry weight centrally
• Upper arms — loose skin along the inner arm becomes more apparent as fat volume decreases
• Chin and neck — submental fat loss can result in a deflated appearance, laxity along the jawline, or the early appearance of jowls
• Inner thighs — less commonly discussed but frequently affected in patients with significant lower-body weight loss
Non-Surgical Options: What Can Help?
For patients in London seeking to address post-weight-loss skin laxity without undergoing traditional surgery, several options exist. The most relevant for mild to moderate laxity is Quantum RF.
Quantum RF
Quantum RF is a radiofrequency-assisted contouring treatment that works beneath the skin's surface. A small cannula delivers bipolar radiofrequency energy into the subdermal tissue, heating it to a controlled temperature. This causes immediate fibroseptal network contraction, visible tightening, and triggers a prolonged collagen remodelling response that continues for up to six months following the procedure.
It is particularly well-suited to patients who have lost significant weight through Ozempic or Mounjaro and are now experiencing loose skin on the abdomen, arms, or neck and chin. Crucially, Quantum RF can address both residual fat deposits and overlying skin laxity in the same treatment session.
Patients who are familiar with FaceTite or BodyTite should note that Quantum RF is the same treatment principle delivered via a newer generation platform.
Surgical Options
For patients with very significant skin redundancy, particularly following large-volume weight loss, surgical excision may be the more appropriate route. This includes procedures such as abdominoplasty (tummy tuck) or brachioplasty (arm lift). Dr Sultan will discuss the full range of options at the consultation and advise on the most appropriate approach based on individual assessment.
Surface Treatments
Non-invasive surface treatments such as radiofrequency microneedling or high-intensity focused ultrasound (HIFU) can produce modest improvements in early or mild laxity. They are not equivalent to Quantum RF in terms of depth of treatment or magnitude of result, and are generally less appropriate for patients with pronounced skin redundancy following significant weight loss.
What to Expect at Consultation
A consultation with Dr Sultan at 8 Hollywood Road, Chelsea, begins with a thorough review of the patient's weight loss history, current weight stability, and aesthetic concerns. It is generally advisable for patients to reach a stable weight before undergoing Quantum RF, as treating skin laxity while the weight is still fluctuating may affect the longevity of results.
Dr Sultan will assess the degree and distribution of skin laxity, discuss realistic outcome expectations, and determine whether Quantum RF, a surgical approach, or a combination is most appropriate.
Frequently Asked Questions
Can Quantum RF treat skin laxity on both the body and the face?
Yes. Quantum RF can be applied to facial areas, including the neck and chin, as well as body areas such as the abdomen and upper arms. The same device is used across treatment zones, with the approach adapted to the anatomy of each area.
Do I need to have finished losing weight before having Quantum RF?
In most cases, yes. Undergoing treatment while actively losing weight may affect results. Dr Sultan will discuss timing during consultation and advise on the most appropriate point in the patient's weight loss journey to proceed.
How long do results last?
Results from Quantum RF are long-lasting. The collagen remodelling stimulated by the treatment is structural and progressive. Maintaining a stable weight following treatment helps preserve outcomes.
Is there a limit to how much skin laxity Quantum RF can address?
Quantum RF is most effective for mild to moderate skin laxity. Patients with very significant skin redundancy, particularly excess skin that hangs or folds, may achieve better results with a surgical approach. This is assessed at consultation.
Final Thoughts
Patients in London considering treatment for post-Ozempic or post-Mounjaro skin laxity are welcome to book a consultation with Dr Sultan at 8 Hollywood Road, Chelsea, SW10 9HY.